Towarzystwo Funduszy Inwestycyjnych PZU SA’s Edwards Lifesciences EW Stock Holding History

Towarzystwo Funduszy Inwestycyjnych PZU SA’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$199K	Buy	2,197 +220	+11%	+$18.4K	0.06%	201
2026 Q1	$158K	Sell	1,977 -316	-14%	-$26.1K	0.05%	205
2025 Q4	$195K	Hold	2,293	–	–	0.05%	189
2025 Q3	$178K	Buy	2,293 +1,723	+302%	+$135K	0.04%	191
2025 Q2	$44.6K	Hold	570	–	–	0.01%	444
2025 Q1	$41.3K	Hold	570	–	–	0.01%	445
2024 Q4	$42.2K	Hold	570	–	–	0.01%	407
2024 Q3	$37.6K	Hold	570	–	–	0.01%	399
2024 Q2	$52.7K	Hold	570	–	–	0.02%	292
2024 Q1	$54.5K	Hold	570	–	–	0.02%	289
2023 Q4	$43.5K	Buy	+570	New	+$39.7K	0.02%	301
2021 Q3	$32.6K	Hold	288	–	–	0.04%	184
2021 Q2	$29.8K	Hold	288	–	–	0.04%	211
2021 Q1	$24.1K	Hold	288	–	–	0.04%	221
2020 Q4	$26.3K	Buy	+288	New	+$23.9K	0.03%	181

Other funds holding EW

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Towarzystwo Funduszy Inwestycyjnych PZU SA's EW Position: Q2 2026 in Review

Towarzystwo Funduszy Inwestycyjnych PZU SA increased its Edwards Lifesciences (EW) stake by 11% in Q2 2026, buying an estimated $18.4K and bringing the position to 2,197 shares worth $199K. The position accounts for 0.06% of the portfolio, ranked #201.

Towarzystwo Funduszy Inwestycyjnych PZU SA first reported a position in EW in Q4 2020 and has held it in 15 quarters since. 973 funds tracked by Wall St. Rank hold EW as of Q2 2026.

Towarzystwo Funduszy Inwestycyjnych PZU SA held 2,197 shares of Edwards Lifesciences worth $199K as of Q2 2026.
Towarzystwo Funduszy Inwestycyjnych PZU SA bought 220 Edwards Lifesciences shares in Q2 2026, an estimated $18.4K.
Edwards Lifesciences made up 0.06% of Towarzystwo Funduszy Inwestycyjnych PZU SA's portfolio in Q2 2026, its #201 holding.
Towarzystwo Funduszy Inwestycyjnych PZU SA first reported a position in Edwards Lifesciences in Q4 2020 and has held it in 15 quarters since.
973 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Towarzystwo Funduszy Inwestycyjnych PZU SA's 13F filing for Q2 2026, filed 7 Aug 2026.